Advertisement

Topics

The Silverstein Foundation for Parkinson’s with GBA, REGENXBIO Inc. & OrbiMed Company Profile

13:03 EDT 23rd March 2019 | BioPortfolio

The Silverstein Foundation is a 501(c)(3) non-profit organization founded in 2017 focused on investing in cutting edge research with the goal of discovering new therapies for the treatment of Parkinson's Disease in glucocerebrosidase (GBA1) mutation carriers. For more information, please visit www.silversteinfoundation.org.


News Articles [1083 Associated News Articles listed on BioPortfolio]

IBM, Michael J. Fox Foundation to research Parkinson’s using AI

IBM is planning to use AI and machine learning to better understand Parkinson’s disease after being awarded a grant from the Michael J. Fox Foundation for Parkinson’s Research.

The Michael J Fox Foundation for Parkinson’s Research

In this interview, filmed at BioPharm in San Francisco, Dr Fintan Walton speaks with to Debi Brooks, Co-Founder of The Michael J Fox Foundation for Parkinson’s Research They discuss the foundation's...

Startup tests Parkinson's device with Michael J. Fox Foundation funding

(University of Delaware) A Mid-Atlantic research team with roots at the University of Delaware has received a $440,000 grant from The Michael J. Fox Foundation for Parkinson's Research (MJFF) to test ...

Gain Therapeutics SA Announces Award of Grant Support from Leading Parkinson’s Research Foundations to Advance Its Proprietary Non Competitive Molecular Chaperones for Parkinson’s Disease

Gain Therapeutics SA (a biotechnology company discovering and developing novel therapeutics to target lysosomal enzymes involved in inborn errors of metabolism and in CNS diseases...

FDA orphan status granted to Regenxbio's Batten disease drug

Regenxbio's RGX-181, being developed as a one-time therapy for late-infantile neuronal ceroid lipofuscinosis type 2 disease,  -More- 

Rare pediatric disease status given to Regenxbio's brain disorder drug

Regenxbio's orphan drug, RGX-181, which is being developed to treat late-infantile neuronal ceroid lipofuscinosis type 2 dise -More- 

Study looks for DNA changes to measure Parkinson's disease

(University of California - San Diego) Researchers at UC San Diego and Arizona State University have received $1.7 million in funding from the Michael J. Fox Foundation for Parkinson's Research to la...

Rocket gets exclusive rights to REGENXBIO's NAV AAV vectors

REGENXBIO Inc. licensed Rocket Pharmaceuticals Inc. exclusive global rights (with rights to sublicense) to use its adeno-associated virus vector NAV AAV9 in the development and commercialization of ge...

Drugs and Medications [165 Associated Drugs and Medications listed on BioPortfolio]

Pramipexole dihydrochloride [sandoz inc]

These highlights do not include all the information needed to use PRAMIPEXOLE DIHYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for PRAMIPEXOLE DIHYDROCHLORIDE TABLETS ....

Pramipexole dihydrochloride [a-s medication solutions]

These highlights do not include all the information needed to use PRAMIPEXOLE DIHYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for PRAMIPEXOLE DIHYDROCHLORIDE TABLETS. ...

Pramipexole dihydrochloride [aurobindo pharma limited]

These highlights do not include all the information needed to use PRAMIPEXOLE DIHYDROCHLORIDE TABLETS safely and effectively. See full prescribing information for PRAMIPEXOLE DIHYDROCHLORIDE TABLETS. ...

Pramipexole [camber pharmaceuticals, inc.]

PRAMIPEXOLE DIHYDROCHLORIDE TabletsRx OnlyHIGHLIGHTS OF PRESCRIBING INFORMATIONThese highlights do not include all the information needed to use PRAMIPEXOLE DIHYDROCHLORIDE tablets safely and effectiv...

Pramipexole [a-s medication solutions]

PRAMIPEXOLE DIHYDROCHLORIDE TabletsRx OnlyHIGHLIGHTS OF PRESCRIBING INFORMATIONThese highlights do not include all the information needed to use PRAMIPEXOLE DIHYDROCHLORIDE tablets safely and effectiv...

PubMed Articles [887 Associated PubMed Articles listed on BioPortfolio]

An acoustic emission characterization of the failure process of shallow foundation resting on sandy soils.

Shallow foundation is a common foundation type that is usually used for small to medium size structures. The bearing ability and the failure mechanism of shallow foundation are the fundamental concern...

Qualitative Evaluation of the Personal KinetiGraphTM Movement Recording System in a Parkinson's Clinic.

Wearable-sensors provide accurate, continuous objective measurements, quantifying the variable motor states of patients with Parkinson's disease (PD) in real time.

The Emerging Evidence of the Parkinson Pandemic.

Neurological disorders are now the leading source of disability globally, and the fastest growing neurological disorder in the world is Parkinson disease. From 1990 to 2015, the number of people with ...

A Comparison of Pain between Parkinson's Disease and Multiple System Atrophy: A Clinical Cross-Sectional Survey.

Pain is frequent in Parkinson's disease (PD) and Parkinson-plus syndrome. This study aimed to assess the prevalence, characteristics, therapy (especially the effect of dopaminergic therapy), and assoc...

Foundation Species, Non-trophic Interactions, and the Value of Being Common.

Foundation species define ecosystems, control the biological diversity of associated species, modulate critical ecosystem processes, and often have important cultural values and resonance. This review...

Clinical Trials [1572 Associated Clinical Trials listed on BioPortfolio]

Parkinson's Repository of Biosamples and Network Datasets (Tracking Parkinson's)

Prospective observational study of Parkinson's disease with repeat clinical assessment and biobanking of blood samples.

Medication Review in Patients on Anti-Parkinson Therapy

To identify patients within the community taking anti-parkinson medications in whom the diagnosis of Parkinson's disease is incorrect and to supervise and clinically monitor the withdrawal...

Parkinson's Families Project

One person in every 500 has Parkinson's and around 127,000 people are living with the condition in the UK. The aim of the study is to identify new genes that predispose or cause Parkinson'...

Neuroimaging Studies of Depression in Parkinson's Disease

The purpose of this study is to investigate similarities and differences in the neural pathways of depressed Parkinson's patients, non-depressed Parkinson's patients, and healthy controls ...

The Parkinson's Disease NeuroGenebank at Scripps Clinic Registry

By creating a neurogenebank from Parkinson's disease patients' blood donations we will ultimately be able to define genes for Parkinson's disease and other neurological conditions.

Companies [1554 Associated Companies listed on BioPortfolio]

The Silverstein Foundation for Parkinson’s with GBA, REGENXBIO Inc. & OrbiMed

The Silverstein Foundation is a 501(c)(3) non-profit organization founded in 2017 focused on investing in cutting edge research with the goal of discovering new therapies for the ...

The Silverstein Foundation for Parkinson’s with GBA & The Michael J. Fox Foundation for Parkinson’s Research

The Bachmann-Strauss Dystonia and Parkinson Foundation

The Bachmann-Strauss Dystonia & Parkinson Foundation was established in 1995 to find better treatments and cures for the movement disorders dystonia and Parkinson's disease and to...

The Michael J. Fox Foundation for Parkinson's Research

Founded in 2000, The Michael J. Fox Foundation for Parkinson's Research is dedicated to ensuring the development of a cure for Parkinson's disease through an aggressively funded research agenda. The F...

The Parkinson Alliance

The Parkinson Alliance is the umbrella organization for the Parkinson's Unity Walk. The Kingston, NJ-based national non-profit organization is dedicated to raising funds to help finance the most promi...

More Information about "The Silverstein Foundation for Parkinson’s with GBA, REGENXBIO Inc. & OrbiMed" on BioPortfolio

We have published hundreds of The Silverstein Foundation for Parkinson’s with GBA, REGENXBIO Inc. & OrbiMed news stories on BioPortfolio along with dozens of The Silverstein Foundation for Parkinson’s with GBA, REGENXBIO Inc. & OrbiMed Clinical Trials and PubMed Articles about The Silverstein Foundation for Parkinson’s with GBA, REGENXBIO Inc. & OrbiMed for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of The Silverstein Foundation for Parkinson’s with GBA, REGENXBIO Inc. & OrbiMed Companies in our database. You can also find out about relevant The Silverstein Foundation for Parkinson’s with GBA, REGENXBIO Inc. & OrbiMed Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Parkinson's Disease
Parkinson's is a progressive neurological condition, affecting one person in every 500, 95% of which are over 40. It is caused by degeneration of more than 70% of the substantia nigra, which depletes the dopamine (the neurotransmitter involved in pro...


Corporate Database Quicklinks



Searches Linking to this Company Record